Related Experiment Video
Updated: May 31, 2026
06:06
Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
Published on: July 22, 2021
Osteoarthritis: an update with relevance for clinical practice
Johannes W J Bijlsma1, Francis Berenbaum, Floris P J G Lafeber
1Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, Netherlands. j.w.j.bijlsma@umcutrecht.nl
Lancet (London, England)
|June 21, 2011
Summary
Osteoarthritis diagnosis is often delayed, limiting treatment effectiveness. Future research aims to identify disease phenotypes for earlier diagnosis and targeted therapies to improve patient outcomes.
Area of Science:
- Rheumatology
- Orthopedics
- Biomarkers
Background:
- Osteoarthritis (OA) is a prevalent chronic joint disease with increasing incidence due to aging and obesity.
- Current diagnosis often occurs late, hindering the efficacy of disease-modifying drugs.
- Pain and functional loss are primary clinical manifestations driving treatment decisions.
Purpose of the Study:
- To highlight the need for improved diagnostic methods in osteoarthritis.
- To emphasize the importance of early detection and disease phenotyping for effective treatment.
Main Methods:
- Review of current diagnostic procedures including imaging and biochemical markers.
- Discussion of limitations in existing methods for early diagnosis and prognosis.
- Exploration of potential for developing more specific and sensitive diagnostic tools.
Main Results:
- Current diagnostic tools are insufficient for early osteoarthritis detection and patient stratification.
- There is a critical need for enhanced imaging and biochemical markers.
- Delineating distinct osteoarthritis phenotypes is expected to improve future treatment strategies.
Conclusions:
- Improved diagnostic methods are crucial for timely osteoarthritis intervention.
- Identifying specific osteoarthritis phenotypes will enable personalized and more effective treatments.
- Further research into novel biomarkers and imaging techniques is essential for advancing osteoarthritis care.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:22Connective Tissue Cell Types
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...